These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Epidemiological and public health aspects of inflammatory rheumatic systemic diseases]. Zink A; Mau W; Schneider M Internist (Berl); 2001 Feb; 42(2):211-6, 219-22. PubMed ID: 11244876 [No Abstract] [Full Text] [Related]
4. Golimumab (simponi) for inflammatory arthritis. Med Lett Drugs Ther; 2009 Jul; 51(1316):55-6. PubMed ID: 19590489 [No Abstract] [Full Text] [Related]
5. Biologic Therapies for Autoimmune and Connective Tissue Diseases. Wolfe RM; Ang DC Immunol Allergy Clin North Am; 2017 May; 37(2):283-299. PubMed ID: 28366477 [TBL] [Abstract][Full Text] [Related]
6. Anti-tumor necrosis factor therapies reduce serum macrophage inflammatory protein-1alpha in ankylosing spondylitis. Akbulut H; Koca SS; Ozgen M; Isik A J Rheumatol; 2010 May; 37(5):1073-4. PubMed ID: 20439531 [No Abstract] [Full Text] [Related]
7. Inflammatory bowel disease and ankylosing spondylitis associated with cutaneous vasculitis, glomerulonephritis, and circulating IgA immune complexes. Peeters AJ; van den Wall Bake AW; Daha MR; Breeveld FC Ann Rheum Dis; 1990 Aug; 49(8):638-40. PubMed ID: 2204314 [TBL] [Abstract][Full Text] [Related]
8. Golimumab: a new anti-TNF-alpha agent for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Voulgari PV Expert Rev Clin Immunol; 2010 Sep; 6(5):721-33. PubMed ID: 20828280 [TBL] [Abstract][Full Text] [Related]
9. [Clinical and immunological analysis of ankylosing spondylitis and rheumatoid arthritis]. Chen LH Zhonghua Nei Ke Za Zhi; 1984 Jan; 23(1):25-7, 62. PubMed ID: 6525901 [No Abstract] [Full Text] [Related]
10. [Physiopathology and therapy of rheumatoid arthritis]. Hashimoto H Nihon Naika Gakkai Zasshi; 1998 Mar; 87(3):402-6. PubMed ID: 9577565 [No Abstract] [Full Text] [Related]
11. Molecular mechanisms of inflammatory bone damage: emerging targets for therapy. Herman S; Krönke G; Schett G Trends Mol Med; 2008 Jun; 14(6):245-53. PubMed ID: 18468489 [TBL] [Abstract][Full Text] [Related]
12. A systematic survey of the HLA B27 prevalence in inflammatory rheumatic diseases. Dequeker J; Decock T; Walravens M; Van de Putte I J Rheumatol; 1978; 5(4):452-9. PubMed ID: 739494 [TBL] [Abstract][Full Text] [Related]
13. [Frequency of antigens of the HL-A system in rheumatoid arthritis and in ankylosing spondylitis in an ethnically homogeneous population]. Marcolongo R; Contu L Reumatismo; 1975; 27(1):170-5. PubMed ID: 1233629 [No Abstract] [Full Text] [Related]
14. [Letter: HL-A antigens in rheumatoid arthritis and ankylosing spondylitis in Sardinia]. Marcolongo R; Contu L Nouv Presse Med; 1974 Sep; 3(32):2023. PubMed ID: 4431706 [No Abstract] [Full Text] [Related]
15. A 15-year exercise program for rheumatoid vasculitis. Marley WP; Santilli TF Scand J Rheumatol; 1998; 27(2):149-51. PubMed ID: 9572643 [TBL] [Abstract][Full Text] [Related]
17. In brief: new indications for secukinumab (Cosentyx). Med Lett Drugs Ther; 2016 Jun; 58(1496):76. PubMed ID: 27249098 [No Abstract] [Full Text] [Related]
18. [Results of French tests of metacortandracin in inflammatory rheumatism]. COSTE F; DELBARRE F; MASSIAS P; DE SEZE S; ROBIN J; DEBEYRE N; RUBENS-DUVAL A; LACAPERE J Rev Rhum Mal Osteoartic; 1955 May; 22(5):385-405. PubMed ID: 13246416 [No Abstract] [Full Text] [Related]
19. The immunology of ankylosing spondylitis and rheumatoid arthritis: a tale of similarities and dissimilarities. Inman RD; El-Gabalawy HS Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S26-32. PubMed ID: 19822042 [TBL] [Abstract][Full Text] [Related]
20. [Clinico-immunological characteristics of patients with rheumatoid arthritis and symptoms of cutaneous vasculitis (cooperative Soviet-Polish study)]. Nasonova VA; Alekberova ZS; Balabanova RM; Sadowska-Wrublewska M; Filipowicz-Sosnowska A; Garwolińska G; Weryńska-Przybylska Z Klin Med (Mosk); 1990 Jun; 68(6):33-7. PubMed ID: 2145468 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]